• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Cancer Res Ther . Novel coronavirus infection (COVID-19) in a 12-year-old boy with acute lymphoblastic leukemia

tetano

Editor, Senior Moderator
J Cancer Res Ther


. 2022 Dec;18(Supplement):S478-S480.
doi: 10.4103/jcrt.JCRT_653_20.
Novel coronavirus infection (COVID-19) in a 12-year-old boy with acute lymphoblastic leukemia


Wulandewi Marhaeni[SUP] 1 [/SUP], Ni Made Yuliari Abdiwati[SUP] 2 [/SUP], Andreas Budi Wijaya[SUP] 3 [/SUP]



Affiliations

Abstract

Pediatric acute lymphoblastic leukemia (ALL) with COVID-19 might still have a risk of severe infection due to immunocompromised condition. The clinical features in oncology population are quite similar to those of previous reports in general pediatric cases. Chemotherapy should be arranged individually to balance the risk between leukemia progressivity itself and COVID-19 complications. Interruptions of therapy must be thought in cases with severe or symptomatic infection of severe acute respiratory syndrome-CoV-2. In this case report, chemotherapy will be started 1 week after the improvement of general condition. Chemotherapy should not be postponed for >14 days.

Keywords: COVID-19; Chemotherapy; leukemia; pediatric.
 
Back
Top Bottom